Would you rather wear glasses or contact lenses, have laser surgery, or put drops in your eyes to see well? Consumers are starting to demand the third option, as new scientific advances have made corrective eye drops possible.
This is big business: A couple of years ago, pharma giant Novartis acquired a company developing a topical treatment for age-related farsightedness (presbyopia), while others are experimenting with eye drops to dissolve cataracts.